Similar to previous reports, XRCC4 expression was significantly different in different immune and molecular subtypes in most cancers, which might suggest that XRCC4 is a potential diagnostic pan-cancer biomarker that involved in immune regulation [33]. The gene discussed is XRCC4; the disease is cancer.